HedgePath, LLC
10% Owner
HedgePath, LLC10% Owner
HedgePath, LLC insider trades: HedgePath Pharmaceuticals (HPPI) SEC Form 4 filings
10% Owner, HedgePath Pharmaceuticals 5 Form 4 filings
5
Form 4 filings
last Jul 12, 2017
2
Grants and awards
filings
1
Conversions
filings
2
Companies
Companies
Where HedgePath, LLC reports to the SEC
About HedgePath, LLC's insider trades
HedgePath, LLC is a 10% owner of HedgePath Pharmaceuticals (HPPI). It has not reported an open-market purchase or sale.
Its filings also include grants and awards (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HPPI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.